INTRODUCTION {#S5}
============

Gastroesophageal reflux (GER) is a physiological process in infants, and refers to the passage of gastric contents into the esophagus with or without regurgitation and vomiting ([@R1], [@R2]). When troublesome symptoms or complications occur, GER becomes a pathological entity called GER disease (GERD) ([@R1],[@R2]). GERD can be associated with poor feeding, weight loss, esophagitis and aerodigestive symptoms. NASPGHAN guidelines and GERD definitions are based on symptoms, although the symptoms are non-specific ([@R1], [@R2]). For high-risk NICU infants and non-verbal patients, there is no gold standard for the definition, diagnosis, or management of GERD, based on pathophysiology. This has led to wide variation in pharmacological therapies ranging from 2% to 30% and prolonged hospitalization by 30 days, incurring an additional economic burden by about \$70,000 per infant ([@R3]--[@R5]).

Common diagnostic tests for GERD may include endoscopy or 24-hour pH-impedance testing. However, in the NICU population endoscopic diagnosis of esophagitis is not readily feasible in distinguishing the severity of GERD. Thus, 24-hour pH-impedance testing is the preferred test. Ionic/fluid movement caused by the passage of liquid, gas or mixed boluses in the esophagus can be detected using 24-hour pH-impedance, specifying the chemical, physical, spatial, and temporal properties of GER events ([@R2], [@R4], [@R6], [@R7]). Electrical impedance measures the resistance to current flow between the adjacent impedance circuits, thus representing changes in conductivity ([@R8], [@R9]). Impedance methods have been used to assess non-erosive reflux disease with the measurement of baseline impedance (BI) values in adults ([@R10]). Distal BI measurements are an indicator of the structural histopathologic changes in the esophageal mucosal epithelium ([@R10]). The degree of BI indicates the level of epithelial damage and has been reported in adults to decrease with increased acid ([@R11]). BI values have a close relationship with time of acid exposure, trans-epithelial resistance (functional) and dilation of intercellular spaces, all of which are reflected in various transformations of the stability (structure) of the esophageal mucosa ([@R10], [@R11]). Specifically, mucosal inflammation has been associated with lower BI, with values \<900 Ωs indicating severe inflammation and \>2000 Ωs indicating normal integrity ([@R12]). Correlation between baseline impedance values and several reflux parameters in children has been recognized previously ([@R13]), as well as a correlation with macroscopic esophagitis ([@R12])

As the safety and efficacy of anti-reflux therapies is still unclear in infants, differences in BI and pH-Impedance metrics may clarify pathophysiology and add to our diagnostic armamentarium. Therefore, our objectives were to characterize and differentiate the changes in esophageal mucosal integrity by determining BI and correlating BI with varying acid reflux indices in symptomatic neonatal ICU infants. We compared the characteristics of pH-impedance with BI threshold categories (\<900, 900-2000, \>2000 Ωs). We hypothesized that lower BI is associated with a higher acid reflux index (ARI, a measure of acid-GERD severity due to prolonged exposure time) and therefore associated with higher symptom prevalence.

MATERIALS AND METHODS {#S6}
=====================

Subjects {#S7}
--------

Infants tested were referred to the Innovative Neonatal and Infant Feeding Disorders Program at Nationwide Children's Hospital, Columbus OH. Infants were consulted for suspicion of GERD due to perisistent troublesome symptoms, such as cardiorespiratory symptoms (couging, sneezing, choking, apnea, bradycardia, desaturation, stridor, or chronic oxygen needs), feeding difficulties (poor oral intake, aspiration, feeding intolerance, symptoms during feeding) or GERD type symptoms (arching/irritiablity and emesis) ([Table 1](#T1){ref-type="table"}). Subjects were included if they underwent 24- hour pH-impedance testing between 2012 and 2015. If the subject had repeat studies, only the first study was included for analysis. Subjects with congenital airway, gastrointestinal (GI) or neurological anomalies were excluded, as well as those who were already receiving acid-suppressive therapy at the time of evaluation. All procedures were performed bedside at Nationwide Children's Hospital Columbus, OH. Informed parental consent and institutional review board approval were obtained prior to the study. Compliance with the Health Insurance Portability and Accountability Act was followed.

pH-Impedance Methods {#S8}
--------------------

Twenty-four hour multichannel intraluminal impedance methods were performed using a pH-impedance probe (Greenfield MMS-Z1-I, 6.4 French, Medical Measurements Systems, Inc. Dover, New Hampshire) connected to a recording device (Ohmega, Laborie Medical Technologies, Mississauga, ON, Canada) as previously published ([@R4], [@R6], [@R7]). The pH-impedance probe-design had six impedance channels (Z1 - Z6) spaced 1.5 cm apart and one pH sensor in the most distal channel. Prior to the study, the probe was calibrated with pH 4.0 and pH 7.0 buffer solutions. The probe was placed nasally in the supine-lying infant with the pH sensor in the distal esophagus at T7- T8 vertebral level, which was verified by x-ray ([@R4], [@R6], [@R7], [@R14]). Infants were tested in the supine position, except during feeding or care times. Trained nursing assistants blinded to the pH-impedance data observed the infant for the entire 24-hour study duration and recorded symptoms, meal times, and cares in real time using event markers on the recording device and written event logs. The nursing assistant's sole responsibility during their shift was to observe and document symptoms in real time at the infant's bedside. In this way, the quality of data acquisition was maintained in our lab.

Determination of BI {#S9}
-------------------

Baseline impedance as measured in impedance channel 6 (distal esophagus) has shown a 100% prediction of grade 3 esophagitis (using endoscopy and histology) as well as macroscopic esophagitis ([@R12]). To develop a non-invasive marker for the test of mucosal integrity, BI was measured in the distal esophagus which is the area of frequent target for refluxate exposure.

Data Analysis {#S10}
-------------

Characteristics of pH-impedance were analyzed using MMS analysis software (v.9.5, Laborie Medical Technologies, Mississauga, ON, Canada), while BI was analyzed using impedance data exported in csv format from MMS analysis software sampled at 10 Hz. The rater (NH) randomly selected ten one-minute windows, every 3 hours during esophageal quiescence, i.e. absence of anterograde and retrograde activity from each patient. Periods during meal times and infant cares were excluded from analysis unless otherwise stated. Mean BI was calculated for the distal impedance channel (Z6) as shown in [Figure 1](#F1){ref-type="fig"}, and subjects were grouped into severe (BI \<900 Ω), moderate (BI 900-2000 Ω), or normal (BI \>2000 Ω) inflammation groups ([@R12]). Additionally, as previous work in children has shown a quicker and reliable method to determine BI by including all impedance data (i.e. retrograde and anterograde events) over the 24-hour study duration ([@R15]), we also calculated the 24-hour mean BI (including all impedance events) for correlation with the randomly selected one minute BI windows samples (excluding impedance events).

As previously published ([@R4], [@R6], [@R7], [@R16]), the following pH-impedance characteristics were analyzed: 1) *pH metrics* included acid reflux index (ARI) as the % of acid (pH\<4) exposure time, number of acid reflux events (ARE) as acid events with pH \<4.0 for \>5 seconds, number of acid reflux events \> 5 minutes, and longest acid reflux duration in seconds. 2) Impedance characteristics included number of ascending acid events (pH\<4), number of weakly acid events (pH 4-7), and total number of events (defined as retrograde reflux with impedance drops \>50% from baseline and reaching at least the Z5 channel). 3) Symptom characteristics including frequency of symptoms (symptoms/hr) and positive symptom association probability (SAP) for pH and impedance events defined as SAP\>95%.

Statistical Analysis {#S11}
--------------------

Analysis was performed using Stata software (v. 14.0, StataCorp, College Station TX). Chi-square tests, t-tests, and ANOVA were used to compare clinical outcomes, and pH-impedance characteristics by BI severity groups (\<900, 900-2000, and \>2000 Ω). A multivariate linear regression model was developed to identify clinical and ph-impedance predictors of BI. Pearson correlation was used to test the correlation between the sample of 10 one-minute windows for BI and the 24-hr method. Median (interquartile range \[IQR\]), mean ± SD, or % are reported, unless stated otherwise. P-values \< 0.05 were considered statistically significant.

RESULTS {#S12}
=======

Clinical and Outcome Characteristics {#S13}
------------------------------------

A total of 198 neonates (105 males), born at 30.4 ± 0.3 (mean ± SD) weeks gestation were evaluated at 43.0 ± 0.4 weeks postmenstrual age (PMA). Of the 198 subjects analyzed, 11(6%) had BI \< 900 Ω, 125(63%) had BI 900 - 2000 Ω, and 62(31%) had BI \> 2000 Ω. Clinical comparisons between the BI severity groups are shown in [Table 1](#T1){ref-type="table"}. Note that the infants in the BI \>2000 Ω group had decreased PPI use at discharge, but experienced higher prevalence of BPD (P \< 0.01) and increased length of stay (P \< 0.01). BI in infants with BPD was 1557 ± 69 Ω vs 1628 ± 47 Ω in infants without BPD (P \< 0.01). BI of infants with tube (nasogastric or orogastric) feeding was 1831 ± 41 Ω compared to 1765 ± 43 Ω for those who were exclusively oral fed at time of study (P = 0.6).

Twenty-four hour pH-impedance Metrics {#S14}
-------------------------------------

Characteristics of pH-impedance between BI groups are shown in [Figure 2](#F2){ref-type="fig"} and [Table 2](#T2){ref-type="table"}. Note that the ARI, number of acid reflux events, number of AREs \>5 min, longest acid reflux, and number of ascending acid events is increased in the BI \< 900 Ω group (P\<0.05). Additionally, although not statistically significant, the BI \< 900 Ω group has a high prevalence of positive symptom correlation (SAP\>95%) for both ascending reflux events and acid events.

Contributory Factors of BI {#S15}
--------------------------

Regression analysis for clinical and pH-impedance characteristics indicate that postmenstrual age (chronological + gestational age). However, chronological age and not gestational age was significantly associated with BI, while controlling for risk factors such as NG-tube use, BPD diagnosis, ARI, and bolus clearance time ([Table 3](#T3){ref-type="table"}). is a significant predictor of BI (β= 17±8, p=0.04). The correlation coefficient between both the 24-hour mean BI and the random 1 minutes window of quiescence was high (r=0.88, p\<0.0001).

DISCUSSION {#S16}
==========

The importance of BI in NICU neonates has not been determined in relation to esophageal pH-impedance measurements. Mucosal inflammation has been associated with lower BI, with values \<900 Ω indicating severity and \>2000 Ω indicating normal integrity ([@R12]). The hallmark of the current study is the inclusion of data from resting state distal esophageal mucosal impedance, which represents changes in conductivity (lowered resistance) of ions at the mucosal level. This study was undertaken to characterize the mucosal integrity marker (BI \<900 Ω, BI 900-2000 Ω, BI \>2000 Ω) and compare clinical characteristics and pH-impedance metrics to clarify pathophysiology. Specifically, in symptomatic NICU infants evaluated for suspicion of GERD: 1) refluxate characteristics are distinct among BI thresholds, 2) subjects with BI \<900 Ω was observed in only 6% of the population, and likely indicates severe esophageal inflammation due to increased acid event frequency, duration, and severity, and although not significant, a high positive symptom correlation with acid (55%) events. 3) subjects with BI \>2000 Ω likely involves little or no inflammation due to minimal acid exposure, and although not significant, a low prevalence of symptom correlation during acid (34%) events, 4) 24- hour BI may be a potential diagnostic tool for rapid and cost effective assessment of esophageal mucosal integrity ([@R11]), in combination with SAP ([@R16]) and pH-impedance metrics ([@R4], [@R6], [@R7], [@R9]), and thus offers careful selection of subjects for personalized anti-reflux therapies.

BI values are reflective of changes in ion movement at the mucosal level during resting state ([@R17], [@R18]). Because electrical impedance is inversely related to the ionic concentration and highly correlated with trans-epithelial resistance, at baseline in health, the impedance is high thereby indicating normal mucosal integrity. Thus baseline impedance function is attributed to the function at the intercellular spaces and in inflammation. When baseline impedance is low, there is greater ion transfer at the mucosal level and therefore increased permeability. Evidence to this pathophysiology is based on histology and baseline impedance studies in animal and human esophageal experimental models which suggested that the greater the distance between the mucosal intercellular spaces the lower the baseline impedance ([@R17], [@R19]--[@R21]). This data also suggests that at low baseline impedance levels, ARI is high and many of the reflux parameters and positive symptom correlations are increased. The degree and duration of acid exposure has been highly correlated to esophageal inflammation across the submucosal spaces affecting the neural elements in the submucosal and myenteric plexus ([@R17], [@R19], [@R21]). Thus, if there is damage to the integrity of esophageal mucosa, the impedance in that recording channel will be affected ([@R12]), and resting state BI is a more sensitive marker reflecting chronicity. Because distal esophagus is the most frequent target for acid exposure, we measured the BI at the distal channel (Z6).

True diagnosis and predictability of GERD remains controversial despite the use of multiple tests ([@R22]). Baseline impedance thresholds can become a major diagnostic marker for GERD prototypes. Understanding the reasons for symptoms remains a conundrum in non-verbal patients, and GERD is a frequent assumption by parents and providers. Unfortunately, the diagnostic criteria, characterization of severity or evidence- based therapeutic strategies for GERD remain unclear in vulnerable infant populations. Added to this, testing methods are not readily available in most centers, and the use of anti-reflux medications remains high despite the uncertainty of benefits and warnings about the side-effects ([@R3], [@R23]). Carefully performed pH-impedance testing with symptom correlation and interpretation can clarify the correlation with troublesome symptoms on a case-by-case basis ([@R7], [@R24]--[@R26]). The indications for GERD diagnosis, for non- pharmacological and pharmacological treatment strategies, for duration of therapies and for medical and surgical therapies remains to be determined in this vulnerable NICU infant population.

Current pH-impedance metrics alone are inadequate as there is no clear consensus in NICU infants on who, when, how, and for how long to treat for GERD. Heightened esophageal sensitivity upon mechanosensitive or chemosensitive esophageal provocation can cause symptoms if the peristaltic reflexes are impaired and dysmotility is evident ([@R27], [@R28]). Similar symptomatology is seen in non-erosive reflux disease in adults that are not responsive to acid-suppressive therapy, or may be the basis for functional esophageal disorders ([@R19], [@R21]). Such a characterization in infants is not yet elucidated. Further studies are needed to distinguish the esophageal motility patterns among those with low vs. high baseline impedance. We also note that the low BI (\<900 Ω) is associated with low ARI, as shown by the lower ranges in the box plots ([Fig 2](#F2){ref-type="fig"}), and such infants often do not respond to acid suppressive therapies. As in older patients ([@R11], [@R17], [@R29], [@R30]), we speculate that such infants may have one of the several potential factors for such pathophysiology: a) symptoms may be due to functional esophageal disorder with onset in neonatal period, b) non-erosive reflux disease, c) non-acid reflux disease, d) eosinophilic esophageal disorders or e) food allergies. Clarification of such differential diagnosis may require further testing using provocative manometry and/or therapeutic interventions ([@R31], [@R32]). We have laid down theoretical framework for potential personalized GERD strategies that may be developed, as follows: 1) A BI \<900 Ω indicates severe inflammation and would support the need for treatment with acid suppressive therapies. It may also provide anticipatory guidance for follow-up and duration of therapy based on response to acid suppressive therapy. 2) For infants with an indeterminate BI (900-2000Ω), development of diagnostic and treatment strategies are needed. We suggest that an indeterminate BI with positive symptom association to acid could be considered pathologic and require treatment with acid suppressives, but indeterminate BI with negative symptom association may likely not need acid suppressive treatment. However, if the there is a positive bolus symptom association, treatments targeting the height and frequency of refluxate may be warranted. 3) If an infant has a BI \>2000 Ω but recurring aerodigestive symptoms, other mechanisms besides GERD should be considered and investigated. Further research studies are needed to test diagnostic and therapeutic strategies based on a combination of diagnostic parameters.

Future directions and limitations from the current study are as follows: 1) The population studied was symptomatic infants referred for GERD. As it is not an ethically appropriate to recruit asymptomatic neonates for pH-impedace testing, data does not exist for control comparisons. However, further testing could be performed to evaluate infants with normal ARI and negative symptom correlation as control comparisons (as these results would indicate no GER pathophysiology). 2) This was a single center study of infants in the inpatient setting; multicenter studies are needed for both, inpatient and outpatient settings. 3) SAP values may be prone to inaccuracy due to human error of charting. However, our lab has tried to minimize these inaccuracies by dedicated staff and training at the bedside to document symptoms in real time. Further studies are needed to develop automated detection of symptoms. 4) The focus of our current study was largely on the distal esophageal acid exposure indices and their correlational effects on the esophageal mucosal integrity marker. Further detailed study is needed to evaluate BI values in relation to anatomical regions of the pharynx, proximal and distal esophagus, and their effects on the motility metrics of the skeletal and smooth muscle portions of the esophagus. 5) Additionally, proximal baseline impedance has been utilized with BCT to determine esophageal dysmotility ([@R33]). We noted that when the distal BI was low, the BCT was larger, suggesting that inflammation modifies motility. Our prior work shows that bowel inflammation modifies the muscarinic signaling mechanisms in the smooth muscle ([@R34]). Further studies are needed to prospectively test this hypothesis. 6) Although there was high correlation with randomly selected 1-min windows and 24-hr BI values, there may be instances where the 24 hour BI is not accurate due to multiple patient factors, hence, clinical discretion is needed. 7) Age has been shown to have an effect on BI and esophagitis ([@R35], [@R36]), while and non-acid / weakly acid reflux has been shown to be related to symptoms, specifically in the infant population and respiratory manifestations ([@R37]--[@R45]). However, as endoscopy was not performed in the current study, further work is needed to gather prospective data regarding subject factors and response to tailored therapies targeting non acid, weakly acid, and acid GER.

*In conclusion*, as clinical suspicion of GERD is often inaccurate, distal baseline impedance is likely a valuable addition to pH-Impedance testing to objectively discern GERD in NICU infants. The inverse relationship of esophageal acid exposure index to esophageal baseline impedance suggests that mucosal disruption may result from acid reflux exposure in these high-risk vulnerable infants. Infants with suspected GERD should be thoroughly investigated before beginning anti-reflux medications or life-style changing medical or surgical therapies. Understanding the pathophysiological basis for symptoms or signs in relation to objectively-diagnosed GERD will pave way for well-targeted therapies and successful outcomes. A combination of SAP, pH-impedance metrics and BI along with clarification of dysmotility mechanisms provides rationale for careful selection of subjects for personalized anti-reflux therapies, either medical or surgical.

We are grateful to Rebecca Moore, MS, RN, for helping with IRB coordination, demographic data extraction and verification.

**STATEMENT OF FINANCIAL SUPPORT:** Supported in part by RO1 NIH DK 068158

**DISCLOSURE STATEMENT:** The authors declare no conflicts of interest

CATEGORY OF STUDY: Translational

![Twenty-four hour pH-Impedance tracing (top panel) and 1-min baseline impedance segment (lower panel).\
Ten 1-minute windows (yellow bars) at rest (during non-mealtimes, and absence of anterograde or retrograde activity) were randomly selected for calculation of distal baseline impedance (BI). The Z6 (in distal esophagus) channel is close to the site of most acid exposure; hence, BI was calculated at this site.](nihms-1512711-f0001){#F1}

![Effect of esophageal inflammation on esophageal acid exposure.\
\*P\<0.05 vs BI \>2000 Ω, †P\<0.05 vs BI 900-2000 Ω. Box plots represent 25^th^ and 75^th^ percentiles; whiskers represent 10^th^ and 90^th^ percentile; median is represented by the black horizontal line and mean by the black dashed line. Acid reflux index (ARI) values are distinct between baseline impedance categories. Note the BI \< 900 Ω (severe inflammation) category has increased ARI, whereas \> 2000 Ω (minimal inflammation) category has decreased ARI.](nihms-1512711-f0002){#F2}

###### 

Clinical characteristics and aerodigestive outcomes stratified by baseline impedance

  Characteristics                                       BI\<900 (N = 11)                             BI 900-2000 (N =125)                           BI\>2000 (N = 62)   P-value
  ----------------------------------------------------- -------------------------------------------- ---------------------------------------------- ------------------- ---------
  **At Birth**                                                                                                                                                          
   Gestational age, wks                                 32.6 ± 5.2[\*](#TFN3){ref-type="table-fn"}   31.1 ± 4.4[\*](#TFN3){ref-type="table-fn"}     28.7 ± 4.3          \<0.01
  **At evaluation**                                                                                                                                                     
  *Reason for GERD referral*                                                                                                                                            
   Cardiorespiratory symptoms, %                        45                                           46                                             27                  0.10
   Feeding difficulty, %                                45                                           41                                             37                  0.87
   Reflux type of symptoms, %                           18                                           30                                             44                  0.09
  *Subject characteristics*                                                                                                                                             
   Postmenstrual age, wks                               41.4 ± 3.6                                   42.1 ± 4.4[\*](#TFN3){ref-type="table-fn"}     45.0 ± 6.1          \<0.01
   Chronological age, wks                               8.8 ± 3.7[\*](#TFN3){ref-type="table-fn"}    11.0 ± 5.8[\*](#TFN3){ref-type="table-fn"}     16.3 ± 7.3          0.02
   Bronchopulmonary dysplasia, %                        27[\*](#TFN3){ref-type="table-fn"}           40[\*](#TFN3){ref-type="table-fn"}             71                  \<0.01
   Breathing support (ventilator: NCPAP: NC: none), %   0: 9: 18: 73                                 0: 3: 35: 62[\*](#TFN3){ref-type="table-fn"}   10: 7: 44: 39       \<0.01
   Feeding method (tube: oral), %                       36: 64                                       27: 73                                         44: 56              0.17
   Milk type (F: F and B: B) %                          0: 55: 45                                    5: 56: 39                                      2: 64: 34           0.62
   Caloric density, cal/oz                              24.6 ± 2.9                                   23.8 ± 2.9                                     25.5 ± 2.7          0.69
   Total fluid volume, ml/kg/day                        141 ± 19                                     144 ± 20                                       135 ± 18            0.81
   Frequency of feeds, \#/day                           8.3 ± 0.8                                    8.0 ± 1.4                                      8.1 ± 1.5           0.07
  **At Discharge**                                                                                                                                                      
   Length of hospital stay, days                        47 ± 35[\*](#TFN3){ref-type="table-fn"}      66 ± 60[\*](#TFN3){ref-type="table-fn"}        115 ± 101           \<0.01
   Breathing support (tracheostomy: NC: none), %        0: 9: 91                                     2: 23: 75[\*](#TFN3){ref-type="table-fn"}      7: 52: 41           \<0.01
   Feeding method (tube: oral) %                        27: 73^[†](#TFN2){ref-type="table-fn"}^      9: 91                                          19: 81              0.11
   Proton pump inhibiter usage, %                       82[\*](#TFN3){ref-type="table-fn"}           66[\*](#TFN3){ref-type="table-fn"}             40                  \<0.01

Values presented as mean ± SD or %.

P\<0.05 vs. BI 900-2000 (Moderate Inflammation),

P\<0.05 vs. BI \>2000 (No Inflammation).

NCPAP- nasal continuous positive airway pressure, NC-nasal cannula oxygen, F-formula, B-breastmilk.

###### 

Comparison of pH-impedance characteristics by severity of esophageal inflammation classified by distal baseline impedance (BI)

  Characteristics                                            BI \< 900 (N = 11)                                                             BI 900 -- 2000 (N = 125)                     BI \>2000 (N = 62)   P-value
  ---------------------------------------------------------- ------------------------------------------------------------------------------ -------------------------------------------- -------------------- ---------
  **Refluxate Characteristics**                                                                                                                                                                               
   Acid reflux index, %                                      21.3 ± 15.3[\*](#TFN7){ref-type="table-fn"}^[†](#TFN6){ref-type="table-fn"}^   8.6 ± 7.3[\*](#TFN7){ref-type="table-fn"}    4.4 ± 4.6            \<0.01
   Acid reflux events, \#/day                                153.6 ± 9.7[\*](#TFN7){ref-type="table-fn"}^[†](#TFN6){ref-type="table-fn"}^   82.4 ± 5.1[\*](#TFN7){ref-type="table-fn"}   45.6 ± 4.1           \<0.01
   Acid reflux events \> 5 min, n                            11.9 ± 2.6[\*](#TFN7){ref-type="table-fn"}^[†](#TFN6){ref-type="table-fn"}^    5.0 ± 0.5[\*](#TFN7){ref-type="table-fn"}    2.5 ± 0.4            \<0.01
   Longest acid reflux, min                                  29.1 ± 4.3[\*](#TFN7){ref-type="table-fn"}^[†](#TFN6){ref-type="table-fn"}^    17.7 ± 1.4[\*](#TFN7){ref-type="table-fn"}   12.3 ± 2.4           0.17
   Acid ascending events, \#/day                             40.6 ± 9.2[\*](#TFN7){ref-type="table-fn"}^[†](#TFN6){ref-type="table-fn"}^    20.9 ± 1.6[\*](#TFN7){ref-type="table-fn"}   13.7 ± 1.5           \<0.01
   Weakly acid ascending events, \#/day                      56.1 ± 13.9^[†](#TFN6){ref-type="table-fn"}^                                   50.1 ± 2.8                                   37.1 ± 3.7           0.10
   Total ascending reflux events, \#/day                     113.6 ± 11.5[\*](#TFN7){ref-type="table-fn"}                                   75.4 ± 3.9[\*](#TFN7){ref-type="table-fn"}   62.7 ± 5.1           0.52
   Bolus clearance time, sec                                 1369 ± 565[\*](#TFN7){ref-type="table-fn"}                                     1083 ± 504                                   1075 ± 343           \<0.01
  **Symptom Characteristics**                                                                                                                                                                                 
  *Symptoms, \#/hour*                                        4.3 ± 0.6                                                                      6.2 ± 0.2[\*](#TFN7){ref-type="table-fn"}    5.7 ± 0.4            0.20
   Cardiorespiratory, \#/hour                                0.9 ± 0.7                                                                      1.4 ± 0.9[\*](#TFN7){ref-type="table-fn"}    1.9 ± 1.6            \<0.01
   Sensory, \#/hour                                          0.5 ± 0.4                                                                      1.3 ± 1.6                                    1.0 ± 1.9            \<0.01
   Physical, \#/hour                                         2.3 ± 1.7                                                                      3.3 ± 1.8                                    3.2 ± 1.9            0.9
  *Prevalence of positive symptom correlation (SAP \>95%)*                                                                                                                                                    
   Ascending bolus reflux, %                                 73                                                                             55                                           56                   0.53
    Cardiorespiratory symptoms, %                            45                                                                             34                                           37                   0.69
    Sensory symptoms, %                                      45                                                                             22                                           26                   0.20
    Physical symptoms, %                                     36                                                                             31                                           19                   0.19
   Acid reflux, %                                            55                                                                             39                                           34                   0.41
    Cardiorespiratory symptoms, %                            45                                                                             23                                           24                   0.26
    Sensory symptoms, %                                      0                                                                              6                                            5                    0.71
    Physical symptoms,%                                      18                                                                             20                                           13                   0.49

Values presented as mean ± SD or %.

P\<0.05 vs. BI 900-2000 (Moderate Inflammation),

P\<0.05 vs. BI \>2000 (No Inflammation).

SAP- symptom association probability. Ascending events are those reaching at least Z5 impedance channel.

###### 

Contributing Factors to Esophageal BI

  Characteristics                  Coefficient ± SE   P-value
  -------------------------------- ------------------ ------------
  Gestational age, days            55 ± 48            0.26
  **Chronological age, days**      **21 ± 7**         **\<0.01**
  Tube feeding                     − 44 ± 90          0.62
  **Bronchopulmonary dysplasia**   **190 ± 88**       **0.03**
  **Acid reflux index %**          **− 28 ± 6**       **\<0.01**
  Acid reflux events, \#/day       − 3 ± 2            0.12
  Bolus clearance time, sec        0.2 ± 0.1          0.22

Values presented as linear regression coefficients ± SE.
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